EP300 promotes tumor stemness via epigenetic activation of CRISP3 leading to lobaplatin resistance in triple-negative breast cancer.

MLA

Wang, Yan, et al. “EP300 Promotes Tumor Stemness via Epigenetic Activation of CRISP3 Leading to Lobaplatin Resistance in Triple-Negative Breast Cancer.” Human Cell, vol. 37, no. 5, Sept. 2024, pp. 1475–88. EBSCOhost, https://doi.org/10.1007/s13577-024-01091-w.

APA

Wang, Y., Zhang, Y., & Qi, X. (2024). EP300 promotes tumor stemness via epigenetic activation of CRISP3 leading to lobaplatin resistance in triple-negative breast cancer. Human Cell, 37(5), 1475–1488. https://doi.org/10.1007/s13577-024-01091-w

Chicago

Wang, Yan, Yi Zhang, and Xiaowei Qi. 2024. “EP300 Promotes Tumor Stemness via Epigenetic Activation of CRISP3 Leading to Lobaplatin Resistance in Triple-Negative Breast Cancer.” Human Cell 37 (5): 1475–88. doi:10.1007/s13577-024-01091-w.